French drugmaker Sanofi has completed its acquisition of US-based Principia Biopharma for $100 per share in cash. The takeover worth altogether $3.7 billion was sealed...
Sanofi has agreed to buy US-based Principia Biopharma for $3.68 billion, strengthening its pipeline of treatments for autoimmune disorders. The deal gives the French...
16.11.2017
- French drugmaker Sanofi has signed an agreement to develop Principia Biopharma’s experimental oral treatment that is seen to show promise in treating multiple sclerosis (MS) and...
